Bristol-Myers Squibb (BMY) Q2 2024 Earnings
Bristol-Myers Squibb reported Q2 2024 revenue of $12.2B, beat analyst consensus of $11.5B by $661.7M. Diluted EPS came in at $2.07, beat the $1.62 consensus by $0.45. Bristol-Myers Squibb reports across 1 business segment, led by Biopharmaceuticals.
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Bristol-Myers Squibb's Q2 2024 earnings report.
Bristol-Myers Squibb (BMY) reported Q2 2024 earnings on July 26, 2024 before market open.
Bristol-Myers Squibb reported revenue of $12.2B and diluted EPS of $2.07 for Q2 2024.
Revenue beat the consensus estimate of $11.5B by $661.7M. EPS beat the consensus estimate of $1.62 by $0.45.
You can read the 10-Q periodic report (0000014272-24-000123) directly on SEC EDGAR. The filing index links above go to sec.gov.